-
1 Comment
DNA Chip Research Inc is currently in a long term downtrend where the price is trading 8.4% below its 200 day moving average.
From a valuation standpoint, the stock is 82.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 12.3.
DNA Chip Research Inc's total revenue rose by 40.4% to $79M since the same quarter in the previous year.
Its net income has increased by 14.7% to $-49M since the same quarter in the previous year.
Based on the above factors, DNA Chip Research Inc gets an overall score of 3/5.
| CurrencyCode | JPY |
|---|---|
| ISIN | JP3548590003 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Exchange | TSE |
| Beta | 0.57 |
|---|---|
| Market Cap | 7B |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
DNA Chip Research Inc. develops DNA microarrays in Japan. The company offers research and development, contract research, and diagnostic support services. It offers Tbone EX Kit for Japanese forensic laboratories in police force and universities. The company also develops EGFR (epidermal growth factor receptor) Liquid gene analysis software, a disease diagnosis program for detecting mutations in the gene encoding EGFR using DNA extracted from plasma samples or cancer tissues and determining drug efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer, as well as focuses on developing a gene panel for testing cancers using sequencing technology. The company was incorporated in 1999 and is based in Tokyo, Japan. As of April 7, 2025, DNA Chip Research Inc. operates as a subsidiary of Mitsui Chemicals, Inc.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2397.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
